Novo Nordisk positions

The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.

As a natural consequence, we have formulated positions on issues of relevance to our business and our role as a global corporate citizen:

The positions presented express our views as well as the context and the background for the position.

Below, Novo Nordisk contact persons are named, from whom more information on each issue can be obtained.

Media representatives are kindly asked to contact our Media Relations Team.

PositionContacts
Access to diabetes care

Charlotte Ersbøll
Corporate Vice President,
Corporate Stakeholder Engagement
+45 3079 6511

 

Climate

Susanne Stormer
Vice President,
Corporate Sustainability
+45 3079 4479

 

Animal experimentation

Mads Krogsgaard Thomsen 
Executive Vice President
and Chief Science Officer
+45 4442 3988

 

Gene technology

Steen Weber Jensen
Vice President
Manufacturing Development
+45 4442 2979

 

Human rights

Susanne Stormer
Vice President,
Corporate Sustainability
+45 3079 4479

 

IPR and patenting

Lars Kellberg
Corporate Vice President,
Corporate Patents
+45 3079 1822

 

Public affairs

Charlotte Ersbøll
Corporate Vice President,
Corporate Stakeholder Engagement
+45 3079 6511

Stem cells

Mads Krogsgaard Thomsen
Executive Vice President
and Chief Science Officer
+45 4442 3988

Use of non-human primates

Mads Krogsgaard Thomsen 
Executive Vice President
and Chief Science Officer
+45 4442 3988

 

 Counterfeit medicinesLars Guldbæk Karlsen 
Senior Vice President
Global Quality
+45 4442 7144